The chemical class known as Junctophilin-3 inhibitors represents a specialized group of organic compounds that modulate the activity of junctophilin-3 (JP3), a protein intricately involved in the formation and maintenance of cellular junctions in excitable tissues such as muscle and brain. These inhibitors are thoughtfully engineered to interact with specific binding sites on the JP3 protein, thereby disrupting its functional roles in facilitating the apposition of cellular membranes, a crucial process for effective signal transmission within excitable tissues. The development and exploration of JP3 inhibitors demand a multidisciplinary approach, encompassing elements of molecular modeling, structural analysis, and in-depth investigations into the precise molecular interactions between these inhibitors and the JP3 protein. This comprehensive strategy aims to optimize the inhibitors for heightened specificity towards JP3, increased potency, and compatibility within the cellular microenvironment. A profound understanding of the structural intricacies of JP3 and its contributions to cellular junction formation is essential for the rational design of effective inhibitors within this chemical class.
The primary objective driving the investigation and design of JP3 inhibitors is to unravel the molecular intricacies that govern cellular junction dynamics mediated by JP3. These inhibitors serve as essential tools for dissecting the mechanisms through which JP3 contributes to the formation of membrane appositions, facilitating efficient communication between cells. By selectively inhibiting JP3, researchers aim to uncover the precise molecular mechanisms that underlie cellular junctions. The ongoing refinement and exploration of JP3 inhibitors are vital for advancing our understanding of cell-cell communication and the fundamental processes that regulate cellular junction dynamics. Through the elucidation of JP3 inhibition, scientists gain a deeper appreciation for the intricate molecular mechanisms that contribute to effective signal transmission within excitable tissues, revealing new insights into the broader cellular significance of JP3 and its influence on cellular junction-related functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
A natural compound with diverse biological activities, curcumin has been suggested to modulate calcium signaling and potentially affect proteins like JPH3 involved in ER-SR interactions. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $184.00 $245.00 | 13 | |
Although known primarily as a non-selective calcium channel blocker, ruthenium red has been reported to inhibit the ryanodine receptor, which is associated with JPH3 in muscle cells. | ||||||
Tetracaine | 94-24-6 | sc-255645 sc-255645A sc-255645B sc-255645C sc-255645D sc-255645E | 5 g 25 g 100 g 500 g 1 kg 5 kg | $66.00 $309.00 $500.00 $1000.00 $1503.00 $5000.00 | ||
An anesthetic compound, tetracaine has been suggested to inhibit ryanodine receptors, which could impact ER-SR interactions and, consequently, JPH3. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene targets ryanodine receptors and might indirectly impact JPH3-related functions. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
A calcium chelator, BAPTA-AM could be used to study the effects of altered calcium levels on JPH3-related processes. | ||||||